Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Barr

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1994
Differential absorption of amoxicillin from the human small and large intestineW H Barr, E M Zola, E L Candler, et al.
Journal of Pharmaceutical Sciences|September 1, 1990
Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage formsJ P Skelley, G L Amidon, W H Barr, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assaysN R Srinivas, W H Barr, W C Shyu, et al.
Journal of Pharmaceutical Science and Technology : the Official Journal of PDA|March 1, 1994
Workshop II report: scaleup of oral extended release dosage formsJ P Skelly, G A Van Buskirk, H M Arbit, et al.
Pharmaceutical Research|December 1, 1993
Scaleup of oral extended-release dosage formsJ P Skelly, G A Van Buskirk, H M Arbit, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pharmaceutical Research|June 19, 2001
Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administrationD Y Mitchell, W H Barr, R A Eusebio, et al.
Journal of Clinical Pharmacology|February 1, 1994
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pharmaceutical Research|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|September 1, 1994
Differential absorption of amoxicillin from the human small and large intestineW H Barr, E M Zola, E L Candler, et al.
Journal of Pharmaceutical Sciences|September 1, 1990
Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage formsJ P Skelley, G L Amidon, W H Barr, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assaysN R Srinivas, W H Barr, W C Shyu, et al.
Journal of Pharmaceutical Science and Technology : the Official Journal of PDA|March 1, 1994
Workshop II report: scaleup of oral extended release dosage formsJ P Skelly, G A Van Buskirk, H M Arbit, et al.
Pharmaceutical Research|December 1, 1993
Scaleup of oral extended-release dosage formsJ P Skelly, G A Van Buskirk, H M Arbit, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pharmaceutical Research|June 19, 2001
Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administrationD Y Mitchell, W H Barr, R A Eusebio, et al.
Journal of Clinical Pharmacology|February 1, 1994
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pharmaceutical Research|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pageof 6